[On the sensitivity of clinically isolated bacterial strains to aminobenzyl and methylphenylisoxazolyl penicillins, with special reference to urinary tract and bile infections].
D000667:Ampicillin / Q000494:pharmacology*; D001660:Biliary Tract Diseases / Q000382:microbiology*; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D003470:Culture Media; D004754:Enterobacter / Q000302:isolation & purification; D004917:Erythromycin / Q000494:pharmacology; D004925:Escherichia / Q000302:isolation & purification; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D007239:Infections; D007612:Kanamycin / Q000494:pharmacology; D007709:Klebsiella / Q000302:isolation & purification; D009827:Oleandomycin / Q000494:pharmacology; D010068:Oxacillin / Q000494:pharmacology*; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D013210:Staphylococcus / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013444:Sulfisoxazole / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000382:microbiology*
D003470:Culture Media; D010406:Penicillins; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D013444:Sulfisoxazole; D000667:Ampicillin; D013752:Tetracycline; D009827:Oleandomycin; D010068:Oxacillin; D013307:Streptomycin; D003091:Colistin